CEOandCo-Founder

Alloy Partners is a venture builder with a radical thesis: that we can build and scale advantaged companies in partnership with corporations and entrepreneurs. Alloy Partners and the University of Notre Dame partnered to establish a first-of-its-kind venture studio and venture fund, the 1842 Studio and 1842 Fund which is aligned with Notre Dame's mission of serving as a "Force for Good" in the world. In close partnership with the University and its vast network of alumni, corporate, community, and academic leaders, the 1842 Studio co-creates startups that address critical societal challenges, including improving health outcomes for vulnerable patient populations. **The Opportunity** Healthcare-associated infections (HAIs) affect 1 in 31 hospital patients daily, kill approximately 99,000 Americans annually, and cost the U.S. healthcare system $28–45 billion in direct costs — yet hospitals still rely on manual, retrospective surveillance that detects infections too late to prevent the worst outcomes. CMS penalties now put 3–4% of Medicare revenue at risk for the worst-performing hospitals, making HAI prevention an existential financial priority for health system leadership. StealthCo is an ambient AI platform co-developed with a top academic medical center that transforms how hospital systems detect, prevent, and respond to infection risks. By continuously monitoring patients through existing hospital camera infrastructure and applying novel computer vision and AI models at the bedside, StealthCo delivers real-time visibility into prevention protocol adherence, early warnings for high-impact infections including VAP, CLABSI, CAUTI, and SSI, and clinical decision support that enables care teams to intervene before infections manifest. Validated with the academic medical center and other health system, StealthCo aims to deliver a 5x ROI, creating millions in value annually through reduced length of stay, recovered CMS reimbursements, and avoided readmission penalties. W